201
202
200
203
204

Address: Calwerstraße 14
72076 Tübingen


Person profile: 07071 29-82311


Fax number: 07071 29-4141


Current information on our studies

We regularly conduct scientific studies on various issues.

Study participants wanted!

We are looking for participants for many studies. Find out more about participating in a study.

Neuropsychiatric Study Center

Supports the GCP-compliant conduct of studies of the Center for Neurology, the University Department of Psychiatry and Psychotherapy and the Department of Neurosurgery by providing central services.

Learn more

Studies after diagnosis

Studies after diagnosis

Name of the study
Explanation
Contact Us
links
Currently no ongoing studies


Name of the study
Explanation
Contact Us
links
Currently no ongoing studies



Name of the study
Explanation
Contact Us
links
BI 1402-0012
The study no longer includes new participants

Investigation of efficacy and safety of the drug BI 1358894 over 12 weeks in patients with borderline personality disorder
anne.rau@med.uni-tuebingen.de
Flyer on the study
Name of the study
Explanation
Contact Us
links
CBASP
Cognitive Behavioral Analysis System of Psychotherapy (CBASP) vs. Behavioral Activation (BA) in inpatients with persistent depressive and treatment-resistant disorders: Effectiveness, moderators and mediators of change
christian.frischholz@med.uni-tuebingen.de


TBS-D
Effects of transcranial direct current stimulation (tDCS) and cognitive training in patients with schizophrenia
Efficacy of bilateral theta burst stimulation in the treatment of depression.
zfh@med.uni-tuebingen.de

To the page
Information for patients
Name of the study
Explanation
Contact Us
Links
Connex 3
Phase III study to investigate a new drug treatment option for schizophrenia - The study drug is taken over six months and is intended to improve thinking and perception in everyday life (e.g. memory, concentration, attention, planning ability, processing speed). The study is randomized, double-blind and placebo-controlled.
Kontakt:
Dr. Anne Rau

anne.rau@med.uni-tuebingen.de

+49 7071 29-86543


Flyer (German language)
Biomarker evaluation to support clinical translation for schizophrenia

Start: 01.09.2021
End: 31.08.2024


Psychoses are a group of disorders of extraordinary heterogeneity. As a result, diagnosis, prognosis and treatment decisions for individual patients pose a major challenge. The project optimizes biomarker signatures of patients at high risk for schizophrenia and patients with defined psychotic disorders. This will be achieved by integrating multimodal patient data and subsequent functional validation of biomarker signatures on patient-derived neurons.


Project leader: Prof. Dr. Hansjürgen VolkmerFunded by

: BMBFProject management organization

: DLRFKZ

: 01EK2101A




Name of the study
Explanation
Contact Us
links
Currently no ongoing studies


Studies by method

Studies by method

Name of the studyExplanationContactLinks
Ghrelin: work versus reward
Study on the effects of ghrelin administration on dopamine and performance.
neuromadlab@klinikum.uni-tuebingen.de
Interested in how stomach and brain communicate?
flyer
website
In search of rewards
Study on the relationship between reward learning and metabolic signaling. How do we process rewards in the brain?
neuromadlab@klinikum.uni-tuebingen.de
Interested in your metabolism. Then learn more:
website
CARE
Computer-assisted risk evaluation and risk-adapted treatment for increased risk of developing psychosis.
psychiatrische-hochschulambulanz@med.uni-tuebingen.de
website
CBASPCognitive Behavioral Analysis System of Psychotherapy (CBASP) vs. Behavioral Activation (BA) in inpatients with persistent depressive and treatment-resistant disorders: Efficacy, moderators, and mediators of changechristian.frischholz@med.uni-tuebingen.de


TBS-DEffects of transcranial direct current stimulation (tDCS) and cognitive training in patients with schizophrenia
Efficacy of bilateral theta burst stimulation in the treatment of depression.
zfh@med.uni-tuebingen.deTo the page
Information for patients
BEDVAR

Eating Behavior and Reward Processing Study. What processes promote the development of binge eating?

neuromadlab@klinikum.uni-tuebingen.deFlyer
StimADHD
Review of the efficacy of transcranial direct current stimulation (tDCS) for ADHD in adults
stimadhd@med.uni-tuebingen.de
To the page
Hormonal contraception, mood and cognitive abilities
Study on the effects of the pill on cognitive abilities and mood
neuromadlab@klinikum.uni-tuebingen.de

Would you like to learn more about the effects of the pill?

Website

Flyer


Name of the study
Explanation
Contact
Links

Biomarker evaluation to support clinical translation in schizophrenia

Start: 01.06.2021End
: 31.05.2024


Psychosis represents a group of diseases signified by enormous heterogeity. As a consequence, diagnosis, prognosis, and treatment decision for individual patients are pretty challenging. Within the project, we shall optimize biomarker signatures of patients with high risk for schizophrenia and with defined psychotic disease. This will be achieved by integration of multimodal patient data and subsequent validation of biomarker signatures with the help of patient-derived neurons.

Project leader: Prof. Dr. Hansjürgen Volkmer

Project funding: BMBF

Project sponsor: DLR

Funding reference number: 01EK2101A



Certificates and Associations